TNFRSF1A and metabolic dysfunction-associated steatotic liver disease: Indeed, transgenic mouse models of NAFLD lacking TNF-α receptors (TNFR − / −) were protected from severe hepatic fat accumulation compared with those with intact TNF-α signaling [16–18].